Previous studies examining systemic biomarkers of BBB dysfunction (in particular, S-100β) suggest the BBB may be compromised in patients with schizophrenia,19,20 however, this is an indirect correlation of BBB dysfunction, and a distinct molecular genetic association between BBB dysfunction and schizophrenia has not been described previously. Here, S100B is linked to schizophrenia.